Rapamune 1 mg coated tablets, MYCOPHENOLATE MOFETIL
SIMA SPK 01
Approved small_molecule active
Quick answer
Rapamune 1 mg coated tablets, MYCOPHENOLATE MOFETIL for End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA
- Phase
- Approved
- Modality
- small_molecule
- Status
- active